The Global sterilization equipment market size was valued at 13.9 billion in 2021 and expected to reach USD 23.19 billion by 2028, at a CAGR of 7.7% during the forecast period 2022-2028. In the sterilisation of medical devices and instruments, sterilisation equipment is critical. Throughout the years, several sterilising techniques have been developed to control and destroy microbial development and prevent the spread of illnesses through medical devices and surgical tools. These methods have been effectively applied to the development of new sterilisation equipment. Sterilization is the process of destroying the living micro-organisms that includes transmissible agents such as spore forms, bacteria, fungi, and unicellular eukaryotic organisms from medical equipment, surface, and fluids and among others. Sterilization is mandatory in the medical industry to improve the efficacy and safety of the instruments. Sterilization can be done by various processes such as chemical, heat, high pressure, irradiation, and filtration. Chronic diseases such as HIV and lethal hepatitis may attack due to the use of unsterilized equipment. Sterilization Equipment Market is growing at a significant rate owing to increase in a number of surgical procedures for chronic diseases (according to World Health Organization, approximately 234.2 Mn major surgeries are undertaken every year around the globe). Moreover, government initiations to protect the public health and increase the use of medical devices also boost the market. The emergence of newer diseases such as Ebola has emphasized to maintain the hygienic environment and proper administration of medical facilities. Furthermore, technological advancements such as low-temperature sterilization and gamma radiation also boost the sterilized equipment market over the forecast period. In addition, acquisition and mergers and FDA approval for the newer processes also upsurge the revenue of sterilization equipment market over the forecast period. For instance, in April 2016, Sterigenics International LLC acquired Nelson Laboratories, Inc. for the expansion of business around the globe. Moreover, in February 2014, Cantel Medical Corp. received ISO registration for novel sterilization process Revox, a Peracetic acid/Hydrogen Peroxide vacuum vapour process at room temperature.